A naukri.com initiative
Bloomberg Quint
1M
135
Image Credit: Bloomberg Quint
Sun Pharma Elevates Kirti Ganorkar As Managing Director
- Sun Pharmaceutical Industries has appointed Kirti Ganorkar as the Managing Director of the company, effective Sept. 1, 2025, succeeding Dilip Shanghvi.
- As part of the restructuring, Kirti Ganorkar will oversee the entire business and all functions within the Mumbai-based drug major.
- Dilip Shanghvi will continue to serve as the Executive Chairman, chairing the company's Board.
- Abhay Gandhi, President and Chief Executive Officer of North America, has decided to leave Sun Pharma, with Richard Ascroft taking over as CEO for North America.
- Kirti Ganorkar's appointment is subject to the approval of shareholders at the upcoming annual general meeting.
- The succession planning process at Sun Pharma highlights the organization's commitment to leadership continuity and strategic governance.
- Ganorkar has been instrumental in driving Sun Pharma's growth in India and played a key role in the company's expansion into specialty products.
- With a background in chemical engineering and an MBA, Ganorkar joined Sun Pharma in 1996.
- Dilip Shanghvi expressed confidence in Ganorkar's leadership abilities and emphasized the importance of in-house talent for Sun Pharma's success.
- Shanghvi will focus on strengthening the company's specialty portfolio and contributing to long-term strategic planning.
Read Full Article
8 Likes
For uninterrupted reading, download the app